AstraZeneca (AZNL)

11,420.00p
   
  • Change Today:
      3.36p
  • 52 Week High: 13,250.00
  • 52 Week Low: 9,642.00
  • Currency: UK Pounds
  • Shares Issued: 1,264.16m
  • Volume: 450,288
  • Market Cap: £144,367m

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest ShareCast News

Germany's Cheplapharm pays AstraZeneca $200m for Atacand rights

By Frank Prenesti

Date: Monday 01 Oct 2018

(Sharecast News) - AstraZeneca said it had agreed a $200m deal with Germany's Cheplapharm Arzneimittel for the European commercial rights to Atacand and Atacand Plus heart and hypertension treatments.

AstraZeneca Regulatory News

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 11,420.00p
Change Today 3.36p
% Change 3.03 %
52 Week High 13,250.00
52 Week Low 9,642.00
Volume 450,288
Shares Issued 1,264.16m
Market Cap £144,367m

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 4
Sell 0
Strong Sell 0
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 13-Aug-2025

Time Volume / Share Price
16:29 176 @ 11,420.00p
16:29 101 @ 11,420.00p
16:29 1 @ 11,420.00p
16:29 3 @ 11,420.00p
16:29 17 @ 11,420.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page